TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: cadence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: angular velocity of hip flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: angular velocity of knee flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction in sigmoidoscopic and histological scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in circulating numbers of CD16+ and CD56+ cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in cytotoxic activity of NK cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: postoperative in-hospital stroke
Endpoint domain: Adverse events/effects
Primary endpoint: Daytime dysfunctional score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathological factor improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left ventricular diastolic functions (LVDF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Agreement for classification of drusen subtypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement for identification of any pigment abnormality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to reach heartburn control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing rate of anal fissures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average cure time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean total IPSS change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean delay from onset to randomization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: baseline stroke severity (mean NIHSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VMCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cerebrovascular outcomes
Primary endpoint: Achieving iPTH 150-300 pg/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Reoperation rate within 12 months
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Quality of life improvement after 3 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Oral discomfort
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Nutritional difficulties
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Increase in toothbrushing practices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean percentage of atelectasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Best sprint times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower risk of non-fatal acute coronary syndrome (ACS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cerebral autoregulation assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acute efficacy of lithium in pediatric bipolarity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: long-term effectiveness of lithium treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: short- and long-term safety of lithium
Endpoint domain: Adverse events/effects
Primary endpoint: Number of log-ins
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean Qaw
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: local injection reaction rate
Endpoint domain: Adverse events/effects
Primary endpoint: unsolicited non‐serious adverse events rate
Endpoint domain: Adverse events/effects
Primary endpoint: well-being score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: plasma melatonin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: cardiorespiratory performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medicare payments for foot-care services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Therapeutic shoe ownership
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Use of shoes when walking outdoors
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Waist-Hip Ratio (WHR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to complete relief of gas-related abdominal discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Vomiting scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Request for rescue anti-emetic
Endpoint domain: Adverse events/effects
Primary endpoint: NP severity index improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dermoscopic features improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: optimal chest tube duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: actual chest tube duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pharmacodynamic target achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HBsAg infection rate in infants
Endpoint domain: Mortality/survival
Primary endpoint: mean anxiety score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention rate over 48 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-union of lumbar spinal bone
Endpoint domain: Mortality/survival
Primary endpoint: Root Mean Square (RMS) of EMG activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful hepatic fat data acquisition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful hepatic ATP data acquisition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prescription of amoxicillin
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Assessment of ACL visualization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in UPDRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients discontinuing due to adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Higher toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Worse HrQOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Higher total mean costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: re-hospitalization from cardiac causes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Dur(25) and Dur(0.9)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C(max) with FEBT compared to OTFC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(0‐Tmax') with FEBT compared to OTFC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T(max) with FEBT compared to OTFC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VPA clearance (Cl)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-year change in mean maximum intimal-medial thickness (IMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Acenocoumarol dose prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduced activation of striatal and cortical brain regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduced levels of dopamine in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increased prolactin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: self-reported PGA at Week 24
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: NYHA class at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CBD clearance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful response (75% repigmentation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Rate of repigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Response to divalproex in preventing depressive episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response to lithium in preventing depressive episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deviation from ideal height of placement of mini-implants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity/specificity rates for fetal hypoxia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of operative deliveries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Improvement in breathlessness (MMRC dyspnea scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: First detectable plasma concentration of fentanyl
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose adjusted AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uremia levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Calcemia levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Phosphoremia levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 1-year occurrence of major cardiovascular outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients who requested narcotics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total dose of dolosal used
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to the first request for analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of stay in the ED
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unscheduled ED visits for cast-related problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Internal sphincter thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rectal urge sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mobility and function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to resolution of vasoplegia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stigma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: concerns about falling
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: daily activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Benign esophageal stricture
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of lung worsening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Peak CPK levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ST re-elevation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Symptoms of conduct disorder, oppositional defiant disorder, and major depressive disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of acute ankle injury
Endpoint domain: Mortality/survival
Primary endpoint: Quality-adjusted life expectancy (QALE)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: improvement of tinnitus perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of HpSA and UBT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: False negatives of HpSA and UBT
Endpoint domain: Adverse events/effects
Primary endpoint: Overtreatment rate
Endpoint domain: Adverse events/effects
Primary endpoint: mean pain scores at 30 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of subjects requiring rescue analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolic control (HbA1c%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: LCN2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TIMP-1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arterial partial pressure of oxygen/fraction of inspired oxygen ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comprehension of three-dimensional ultrasound concepts
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Effective radiation dose (ED)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of circulating CD4+ T-cells specific for vaccine antigens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Solicited local reactions
Endpoint domain: Adverse events/effects
Primary endpoint: vivax reappearance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in time-weighted average HIV RNA from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in time-weighted CD4+ T-cell count from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: early wound healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fussiness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: regulation problem
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Haematological cytopenias
Endpoint domain: Adverse events/effects
Primary endpoint: Evaluation of inflammatory hindfoot involvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative rejection frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: rejection-free interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: waiting time to transplantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain reduction immediately postintervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure Pain Threshold (PPT) at thumb carpometacarpal joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure Pain Threshold (PPT) at median nerve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure Pain Threshold (PPT) at radial nerve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accuracy level
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Fasting serum hippuric acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Injury risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Adherence to the 11+ programme
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patient understanding of risks and benefits
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ease of understanding of multimedia module
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: degree of pain-relieving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma apoC‐III levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: HDL apoC‐III levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: LpB:C‐III levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sporozoite rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Indoor resting density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relative expression levels of interleukin (IL)1B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: exercise-induced bronchoconstriction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: mini-nutritional assessment score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of streptococcal pharyngitis
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of acute otitis media
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of i.n. morphine for postoperative analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Slope of 1/SCr vs time plot
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Subjective and objective preference for fat type
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Vein prominence and depth of metacarpal space
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postexercise myofibrillar protein synthetic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in physical activity through stair climbing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: opening urethral pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total urinary incontinence episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in fat-free mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in % fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in maximal strength (chest and leg press)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive response to diagnostic tests for MG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Facial rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of OP symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of serum KL-6 in detecting drug induced lung disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: minor perioperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: size of the incision
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: difficult cannula changes
Endpoint domain: Adverse events/effects
Primary endpoint: Platelet function assessed by MEA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Subsequent bleeding risk
Endpoint domain: Adverse events/effects
Primary endpoint: EPS-WBC counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Accuracy of cytological examination and p53 staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerability of scalp cooling
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in fungal burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Retention rate of families receiving the intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Levels of organizational difficulties reported by mental health professionals
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Intervention-related difficulties
Endpoint domain: Adverse events/effects
Primary endpoint: plaque reduction at the gingival margin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment success rates (> 75% improvement from baseline)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kansas City Cardiomyopathy Questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: European QOL 5D Visual Analog Scale score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean change in HbA1c level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: weight maintenance success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes